Abstract
Pseudogenes are classically thought of as nonfunctional DNA sequences due to their inability to be translated, or to produce a functional protein. Gap junctions, a multiprotein complex made of proteins called connexins, are involved in intercellular communication and are deregulated in many cancers. Connexin43 (Cx43) is the only connexin for which a pseudogene has been reported so far. The Cx43 pseudogene (ΨCx43) has all of the features of an expressed gene. We identified the presence of a ΨCx43 mRNA transcript in several cancer cell lines and in none of the normal mammary epithelial cells studied. Using an in vitro translation assay, we found that the ΨCx43 coding plasmid could be translated into a 43 kDa protein. This was further confirmed by expressing a ΨCx43-green fluorescence protein fusion protein in breast cancer MCF-7 cells. We then examined the functional significance of the ΨCx43. In both MTT growth and colony formation assays, significant growth inhibition was observed, a feature common to cells overexpressing the Cx43 gene. However, using a scrape-loading assay, we could not detect any effect on gap junctional intercellular communication. Based on our findings, ΨCx43 joins and enlarges the thus far restricted group of functionally transcribed and translated pseudogenes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ . (1990). J. Mol. Biol., 215, 403–410.
Andrea JE and Walsh MP . (1995). Biochem. J., 310 (Part 3), 835–843.
Bergoffen J, Scherer SS, Wang S, Oronzi Scott M, Bone LJ, Paul DL, Chen K, Lensch M W, Chance PF and Fishbeck KH . (1993). Science, 262, 2039–2042.
Boschan C, Borchert A, Ufer C, Thiele BJ and Kuhn H . (2002). Genomics, 79, 387–394.
Britz-Cunningham SH, Shah MM, Zuppan CW and Fletcher WH . (1995). N. Engl. J. Med., 332, 1323–1329.
Cai J, Jiang WG and Mansel RE . (1998). Int. J. Mol. Med., 1, 273–278.
Carystinos GD, Bier A and Batist G . (2001). J. Mamm. Gland Biol. Neoplasia, 6, 431–440.
Carystinos GD, Kandouz M, Alaoui-Jamali MA and Batist G . (2003). Mol. Pharmacol., 63, 821–831.
Chakrabarti R, McCracken JB, Chakrabarti D and Souba WW . (1995). Gene, 153, 163–199.
Elfgang C, Eckert R, Lichtenberg-Frate H, Butterweck A, Traub O, Klein RA, Hulser DF and Willecke K . (1995). J. Cell Biol., 129, 805–817.
El-Fouly MH, Trosko JE and Chang CC . (1987). Exp. Cell Res., 168, 422–430.
Fishman GI, Eddy RL, Shows TB, Rosenthal L and Leinwand LA . (1991). Genomics, 10, 250–256.
Flagg-Newton J and Loewenstein WR . (1979). J. Membr. Biol., 50, 65–100.
Foote CI, Zhou L, Zhu X and Nicholson BJ . (1998). J. Cell Biol., 140, 1187–1197.
Harrison P, Kumar A, Lan N, Echols N, Snyder M and Gerstein M . (2002). J. Mol. Biol., 316, 409–419.
Harrison PM and Gerstein M . (2002). J. Mol. Biol., 318, 1155–1174.
Hirotsune S, Yoshida N, Chen A, Garrett L, Sugiyama F, Takahashi S, Yagami K, Wynshaw-Boris A and Yoshiki A . (2003). Nature, 423, 91–96.
Hirschi KK, Xu CE, Tsukamoto T and Sager R . (1996). Cell Growth Differ., 7, 861–870.
Jordan K, Solan JL, Dominguez M, Sia M, Hand A, Lampe PD and Laird DW . (1999). Mol. Biol. Cell, 10, 2033–2050.
Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Laing JN, Parry G, Mueller RF and Leigh IM . (1997). Nature, 387, 80–83.
Kleene KC and Mastrangelo MA . (1999). Genomics, 61, 194–200.
Korneev SA, Park JH and O'Shea M . (1999). J. Neurosci., 19, 7711–7720.
Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD and Alaoui-Jamali MA . (1999). Cancer Res., 59, 4104–4110.
Laird DW, Jordan K and Shao Q . (2001). Methods Mol. Biol., 154, 135–142.
McCarrey JR . (1990). Nucleic Acids Res., 18, 949–955.
Mighell AJ, Smith NR, Robinson PA and Markham AF . (2000). FEBS Lett., 468, 109–114.
Moorby C and Patel M . (2001). Exp. Cell Res., 271, 238–248.
Moran JV, DeBerardinis RJ and Kazazian Jr HH . (1999). Science, 283, 1530–1534.
Paznekas WA, Boyadjiev SA, Shapiro RE, Daniels O, Wollnik B, Keegan CE, Innis JW, Dinulos MB, Christian C, Hannibal MC and Jabs EW . (2003). Am. J. Hum. Genet., 72, 408–418.
Puget N, Gad S, Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM and Mazoyer S . (2002). Am. J. Hum. Genet., 70, 858–865.
Renaudie F, Yachou AK, Grandchamp B, Jones R and Beaumont C . (1992). Mamm. Genome, 2, 143–149.
Sorge J, Gross E, West C and Beutler E . (1990). J. Clin. Invest., 86, 1137–1141.
Sun R, Elsea SH, Patel PI and Funk CD . (1998). Cytogenet. Cell Genet., 81, 79–82.
Tanooka H, Ootsuyama A and Sasaki H . (1998). Cancer Res., 58, 5649–5651.
Thiele H, Berger M, Skalweit A and Thiele BJ . (2000). Eur. J. Biochem., 267, 5473–5481.
Torrents D, Suyama M, Zdobnov E and Bork P . (2003). Genome Res., 13, 2559–2567.
Uechi T, Maeda N, Tanaka T and Kenmochi N . (2002). Nucleic Acids Res., 30, 5369–5375.
Venance L, Piomelli D, Glowinski J and Giaume C . (1995). Nature, 376, 590–594.
Vine AL and Bertram JS . (2002). Cancer Metastasis Rev., 21, 199–216.
Willecke K, Jungbluth S, Dahl E, Hennemann H, Heynkes R and Grzeschik KH . (1990). Eur. J. Cell Biol., 53, 275–280.
Yamasaki H and Naus CC . (1996). Carcinogenesis, 17, 1199–1213.
Zhang CL, Tada M, Kobayashi H, Nozaki M, Moriuchi T and Abe H . (2000). Oncogene, 19, 4346–4353.
Zhang Z, Harrison PM, Liu Y and Gerstein M . (2003). Genome Res., 13, 2541–2558.
Acknowledgements
This work was supported by grants from the Canadian Breast Cancer Research Initiative, McGill Center for Translational Research in Cancer & Montreal Breast Cancer Foundation. We are thankful to Dr N Benlimame for her valuable help in microscopy.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kandouz, M., Bier, A., Carystinos, G. et al. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene 23, 4763–4770 (2004). https://doi.org/10.1038/sj.onc.1207506
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207506
Keywords
This article is cited by
-
Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
Cancer Cell International (2020)
-
Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma
BMC Medical Genomics (2019)
-
TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis
BMC Cancer (2018)
-
Expression of evolutionarily novel genes in tumors
Infectious Agents and Cancer (2016)
-
Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
BMC Cancer (2015)